OHAMR Call for proposals 2026

General Information

• Type: Partner looking for project
• Organisation: HEMEX
• Country: Belgium (BE)
• Career stage: Other.

Research area

• Scientific area(s) of the call:
  1. Topic 1: Identify and develop new combination treatments using existing or innovative antimicrobials or antimicrobial with adjunctive treatments to extend drug efficacy and combat resistance.
• One Health Setting:

  H - Human Health

• Keywords:

  Drug discovery; API manufacturing; Clinical trials; PK/PD; Treatment adherence

• Brief description of your expertise / expertise you are looking for:

  HEMEX delivers end-to-end pharmaceutical and clinical development solutions, from drug discovery to commercialisation. Leveraging its integrated API manufacturing platform and strategic alliance, HEMEX provides drug discovery support, formulation development, PK/PD, BA/BE studies, and scalable API production. With its Global Clinical Network Alliance of 130+ experts across Europe, the US, and India, HEMEX executes GCP-compliant multinational trials, regulatory guidance, and QA systems inspected by FDA, EMA, and WHO, enabling the translation of antimicrobial innovations into safe, affordable, and scalable One Health solutions.

• Brief description of your project / the project you would like to join:

  HEMEX seeks to join OHAMR consortia under Topic 1 and Topic 2, contributing to the development of combination antimicrobial therapies and tools to improve adherence to treatment protocols. We offer integrated support from drug discovery and API manufacturing to PK/PD, formulation, pragmatic clinical trials, digital adherence solutions, and regulatory compliance. Our end-to-end approach enables rapid testing, scale-up, and real-world implementation across human, animal, and One Health settings.

Mohamed Hussien

• Organisation: HEMEX
• Position: Chief Commercial Officer
• E-mail: mohamed.hussien@hemex.ch